Marijuana stocks skyrocketed on the first trading day after California legalized retail sales, unleashing the largest legal market in the country. Thanks to the new California marijuana laws allowing recreational use for people ages 21 and up as of Jan. 1, imbibers are bombarding dispensaries. Lines snake around the block as if Apple just released a new iPhone.
The new marijuana ETF that rolled out only one week prior — ETFMG Alternative Harvest ETF — blasted 9%. It’s up 18% in just one week. Its Canadian counterpart with many overlapping holdings, Horizons Marijuana Life Sciences ETF, lit up 12%.
Medreleaf blasted 29%, giving new meaning to getting high. Aurora Cannabis and Emerald Health Therapeutics rallied 24% and 20%, respectively. Canopy Growth — the world’s largest marijuana stock by market cap — popped 9.4%.
At the same time, a new marijuana industry report from ArcView Market Research poured gasoline on the proverbial bonfire.
“The total economic output from legal cannabis will grow 150% from $16 billion in 2017 to $40 billion by 2021,” Arcview said in a statement. “ U.S. consumer spending on legal cannabis in 2021 of $20.8 billion will generate $39.6 billion in overall economic impact, 414.000 jobs, and more than $4 billion in tax receipts.”
Here are some other notable findings Arcview shared in its report, “US Legal Cannabis: Driving $40 Billion Economic Output”:
-
“The legalization of adult-use sales in California will lead to the creation of nearly 99,000 cannabis industry jobs in the state by 2021, about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced effects are considered.
-
By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states.
-
Six of the early movers in legal adult-use implementation (California, Colorado, Massachusetts, Nevada, Oregon, and Washington) will account for more than 60% of that $39.6 billion in 2021 total economic output. Medical-use states will see a far less positive economic impact, while the hold-out states will see none.
-
The legal cannabis industry may have been a key factor in lowering Colorado’s unemployment rate to one of the lowest in the nation.
-
Conservative estimates show more than $1 billion dollars in wholesale, excise, and cannabis-specific sales taxes were taken into state treasuries during 2016. That number is forecast to grow to just over $1.4 billion in 2017 and then to nearly $2.8 billion by 2021. With additional state and local general sales taxes, that 2021 figure could be between $4 billion and $4.7 billion.”
ETFMG Alternative Harvest ETF, trading under the ticker MJX, tracks 30 companies “likely to benefit from the increasing global acceptance of various uses of the cannabis plant.”
It makes sense that ETFMG Alternative Harvest ETF includes biotech and pharmaceutical companies. But the handful of tobacco companies in the portfolio is baffling. It’s unclear how they would benefit.
This $0.16 Marijuana Stock Expected to Announce “Record-Breaking Quarter”…
“It all looks like a bit of a stretch, almost oxymoronic, as many analysts argue that legalization would harm big pharma, tobacco, alcohol and the prison industry the hardest,” said Javier Hasse. He’s a cannabis reporter and author of the forthcoming book, Start Your Own Cannabis Business (Entrepreneur Media, April 2018).
ETFMG Alternative Harvest ETF was formerly the Tierra XP Latin America Real Estate ETF that traded under the ticker LARE.
| ETFMG Alternative Harvest ETF (MJX) Holdings | ||
| Company | Stock Ticker | % Of Holdings |
| Cronos Group Inc | MJN CN | 8.97% |
| Canopy Growth Corp | WEED CN | 6.53% |
| Medreleaf Corp | LEAF CN | 5.84% |
| Aurora Cannabis Inc Com | ACB CN | 5.77% |
| Canntrust Holdings Inc | TRST CN | 5.07% |
| GW Pharmaceuticals Plc | GWPH | 4.46% |
| Insys Therapeutics Inc | INSY | 3.80% |
| Cannimed Therapeutics Inc | CMED CN | 3.47% |
| Turning Point Brands Inc | TPB | 2.92% |
| Huabao Intl Hldg | 336 HK | 2.81% |
| Emerald Health Therapeutics In Com | EMH CN | 2.81% |
| Organigram Holdings Inc | OGI CN | 2.66% |
| 22nd Century Group Inc | XXII | 2.60% |
| Scandinavian Tobac | STG DC | 2.58% |
| Arena Pharmaceuticals Inc | ARNA | 2.57% |
| Gima Tt Spa | GIMA IM | 2.55% |
| Scotts Miracle Gro Co | SMG | 2.54% |
| Imperial Brands Plc | IMB LN | 2.49% |
| Brit Amer Tobacco | BATS LN | 2.47% |
| Schweitzer-mauduit Intl Inc | SWM | 2.46% |
| Swedish Match | SWMA SS | 2.41% |
| Altria Group Inc | MO | 2.40% |
| Philip Morris Intl Inc | PM | 2.39% |
| Japan Tobacco Inc | 2914 JP | 2.37% |
| Vector Group Ltd | VGR | 2.35% |
| Universal Corp Va | UVV | 2.33% |
| Corbus Pharmaceuticals Holdings Com | CRBP | 2.26% |
| Cara Therapeutics Inc | CARA | 2.18% |
| Supreme Cannabis Co | FIRE CN | 2.13% |
| Isodiol International Inc | ISOL CN | 1.83% |
| Supreme Pharmaceuticals Inc | FIRE CN | 0.00% |
| Cash & Other | Cash & Other | 1.97% |
| Source: http://www.mjxetf.com as of Jan. 2 2018 |
Source: Forbes.com by Ky Trang Ho | Original Link
— TRENDING NOW—
|
9 Stocks to Hold Forever
One of the companies highlighted in this report controls the smartphone market and now has its sights set on owning a bigger technology. It has the potential to be the most valuable stock in the history of investing. You need to find out the name of this company before the rest of the market does. |
